Please login to the form below

Not currently logged in
Email:
Password:

GE Healthcare

This page shows the latest GE Healthcare news and features for those working in and with pharma, biotech and healthcare.

The end of pharma

The end of pharma

Glucose monitoring companies cooperate with diabetes pharma companies. In the market for medical technology, companies like Philips, Siemens and GE Healthcare sell integrated systems that optimise health economic outcomes.

Latest news

  • Roche/GE’s digital medicine alliance bears first fruit Roche/GE’s digital medicine alliance bears first fruit

    the software – and adding in GE’s medical imaging and monitoring equipment technologies. ... Workflows around tumour boards can be inefficient,” commented Tom McGuinness, chief executive of GE Healthcare Imaging.

  • D-day: time to make digital deliver D-day: time to make digital deliver

    There are encouraging signs that the penny is dropping. For example, at the beginning of 2018, Roche Diagnostics announced a partnership with GE Healthcare to jointly develop and co-market digital ... Chris Ross is a freelance writer specialising in the

  • Medical AI gets £50m boost and five new centres in UK Medical AI gets £50m boost and five new centres in UK

    AI is one of the one of four ‘Grand Challenges’ in the UK government’s industrial strategy, and the country has become a hot spot for AI in healthcare, home to ... The five new medical centres will bring together doctors, businesses and academics

  • Roche and GE Healthcare plan 'industry first' digital platform Roche and GE Healthcare plan 'industry first' digital platform

    Roche and GE Healthcare are joining forces to develop clinical decision support software that they say will be the first of its kind. ... Kieran Murphy, GE Healthcare’s president and CEO, said: “This is the first time that two major players in

  • EMA unveils draft guidelines for Alzheimer’s disease research EMA unveils draft guidelines for Alzheimer’s disease research

    Although the last few years have seen a number of Alzeimer's diagnostics approved, among them GE Healthcare Vizamyl (flutemetamol) and Piramal's Neuraceq (florbetaben F18), research progress for a treatment

More from news
Approximately 10 fully matching, plus 49 partially matching documents found.

Latest Intelligence

  • Shanks v Unilever? Or David v Goliath? Shanks v Unilever? Or David v Goliath?

    being Kelly and Chiu v GE Healthcare Ltd [2009] EWHC 181 (Pat).

  • Going the distance Going the distance

    Having found herself moving increasingly close to the business side of the company's operations Pascale then took a year off to do an MBA, before joining GE Healthcare, whose health ... manager roles, first covering Europe, the Middle East and Africa,

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    includes equity purchase. 531. Vital Signs/. CareFusion. Acquisition. Vital Signs is the respiratory care and anesthesiology product manufacturer division of GE Healthcare.

  • Interview: John Dineen, GE Healthcare Interview: John Dineen, GE Healthcare

    But it's in molecular medicine that GE Healthcare connects most directly with biopharmaceutical companies, building biotherapy manufacturing capability and developing diagnostics. ... GE Healthcare. The division Dineen leads is GE's only business with

  • Achieving consensus

    Campaign:Standardising diagnostic techniques. Timescale:March 2009 to present. Over the past 18 months, Succinct Healthcare Communications, GE Healthcare and eminent European healthcare professionals have been collaborating in a medical education

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....